The present invention is directed to methods of modulating viral replicationin vivo comprising administering to an individual a therapeutically orprophylactically effective amount of a composition comprising argininedeiminase modified with polyethylene glycol, to methods of concurrentlymodulating viral replication and treating cancer, and to methods of modulatingnitric oxide levels in a patient, among others.
